trending Market Intelligence /marketintelligence/en/news-insights/trending/729Vq35lFznicluxQzh1zA2 content esgSubNav
In This List

Eleven Biotherapeutics plans common stock offering

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Eleven Biotherapeutics plans common stock offering

Eleven Biotherapeutics Inc. plans to offer $12.5 million of its common stock.

The company plans to use the net proceeds to continue funding the clinical development of Vicinium and for general corporate purposes, which may include capital expenditures and funding our working capital needs.

H.C. Wainwright & Co. LLC will act as the sole book-running manager for this offering.